Losartan Potassium Tablet, Film Coated
Product Images NDC 71335-1136

This appears to be a product label for medication called Losartan Potassium 25mg tablets made by RA CHEM PHARMA LIMITED. This medication is used to treat high blood pressure and heart failure. The label provides directions to store the medication at room temperature between 20°-25°C (68°-77°F). The label also includes a National Drug Code (NDC) number and an expiration date.*

The text is describing data related to a medical study comparing the effectiveness of Atenolol and Losartan Potassium in reducing the primary endpoint (not specified in the given text). The study was conducted for a period of 66 months, and the adjusted risk reduction achieved by Losartan Potassium was noted to be 13%, significant with a p-value of 0.021.*

This is a clinical trial report that shows the percentage of patients who had a fatal or non-fatal stroke while taking either Atenolol or Osartan Potassium. The report also states that the adjusted risk reduction for stroke was 25% with a p-value of 0.001. The graph shows the study month (up to 60 months) for both medications.*

This appears to be a table showing the overall results of a study that analyzed the effects of Losartan Potassium and Atenolol on patients with various medical conditions. The study included patients under 65 years of age with and without diabetes or a history of CVD. The table also shows the number of female and male patients, as well as their race. The primary composite event analyzed in the study was stroke (fatal/non-fatal). Hazard ratios are shown for both Losartan Potassium and Atenolol, adjusted for baseline Framingham risk score and level of electrocardiographic left ventricular hypertrophy. As the table may contain some unreadable characters, it is best to double-check the data if using it for research purposes.*

This appears to be a graph or chart without any clear description or context. Therefore, a useful description cannot be generated based solely on this text.*